CE certified hyaluronic acid dermal filler (Intraline Two listing on EU and UK Intraline sites)
Manufactured in Sweden in accordance with applicable medical device regulations
CE certified hyaluronic acid dermal filler (Intraline Two listing on EU and UK Intraline sites)
Manufactured in Sweden in accordance with applicable medical device regulations
Hyaluronic Acid Filler
Description
Intraline Two is a biphasic, cross-linked hyaluronic acid dermal filler without lidocaine, designed for the correction of medium to deep wrinkles, lip enhancement, and facial contouring. The gel uses spherically shaped HA particles (20 mg/ml) to provide high viscosity, lifting capacity, and natural-looking volume restoration in areas such as nasolabial folds, marionette lines, perioral “smoker’s lines”, lips, chin, jawline, cheeks, and for non-surgical rhinoplasty.
Bnefits
Treats medium to deep wrinkles and folds, including nasolabial folds and marionette lines
Enhances and defines lips, including cupid’s bow, with high-definition results
Provides effective facial contouring for cheeks, chin, and jawline
Suitable for non-surgical rhinoplasty to refine nasal shape
Biphasic gel with spherical HA particles designed for smoother, natural results
High viscosity and large particle size for strong lifting and volumizing effects
Non-animal, highly purified HA with reduced risk of hypersensitivity
Long-lasting effect, typically up to 12 months depending on area and patient factors
Integrates well with tissue for natural feel and appearance
Supplied in prefilled syringe with sterile needles for precise professional use
Injectable, transparent viscoelastic biphasic hyaluronic acid gel
Large sphere size particles for deep-set wrinkle correction and contouring
Non-animal, bacterial fermentation-derived HA
Packaging
1 x 1.0 ml prefilled glass syringe
2 x 27G 1/2" Terumo needles
2 traceability labels
Package insert
Sterile blister pack
Usage
For professional use only by appropriately trained and qualified medical practitioners.
Store and inspect the syringe and packaging to ensure sterility and that the product is within its expiry date before use.
Cleanse and disinfect the treatment area thoroughly; remove any makeup or skincare products.
Attach the supplied 27G needle securely to the prefilled syringe under aseptic conditions.
Inject slowly into the mid-dermis to lower dermis or upper subcutaneous layer, depending on the indication and treatment area.
Use appropriate injection techniques (e.g. linear threading, serial puncture, fanning) to achieve even distribution.
Do not exceed recommended volumes per area; typical maximum is 2 ml per treatment site per session as per professional guidelines.
After injection, gently massage the treated area to ensure uniform distribution of the gel and to smooth any irregularities.
Dispose of any unused product, used needles, and syringes as clinical biohazard waste according to local regulations.
Advise patients to avoid makeup on treated areas for at least 12 hours and to avoid extreme temperatures, saunas, and strenuous exercise for a few days post-treatment.
Contraindications
Known hypersensitivity or allergy to hyaluronic acid or any component of the formulation.
Presence of acute or chronic skin disease, infection, or inflammation (e.g. rashes, hives) at or near the planned injection site.
Pregnant or breastfeeding women.
Patients under 18 years of age.
History of severe allergies or anaphylactic reactions without appropriate specialist evaluation.
Injection into areas with permanent implants or concurrent aesthetic treatments (e.g. laser, radiofrequency) at the same site.
Active herpes simplex infection in the treatment area; patients with a history of cold sores should be managed according to professional protocols.
Patients with uncontrolled autoimmune or connective tissue disorders unless cleared by a specialist.
Adverse Effects
Transient pain or tenderness at the injection site
Redness (erythema) and swelling in the treated area
Bruising or haematoma formation
Itching or mild irritation
Firmness or nodules at the injection site
Discolouration at or near the treated area if injected too superficially
Rare but serious events such as vascular occlusion, tissue necrosis, or infection if incorrectly administered
Hypersensitivity reactions or granuloma formation (rare)
Storage Conditions
Store between 2°C and 25°C in a controlled environment.
Do not freeze the product.
Protect from direct sunlight and excessive heat.
Keep in original packaging until use to maintain sterility.
Do not use if packaging is damaged or if the solution appears cloudy or contains particulates.
Keep out of reach of children.
Duration
Single session with effects typically lasting up to 12 months; repeat treatments can be performed as required following professional evaluation.
Onset
Immediate visible improvement in volume and wrinkle correction after injection, with optimal results apparent once any initial swelling settles over several days.
